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Abstract 
Eukaryotic cells repair thousands of lesions 
arising in the genome at each cell cycle. The 
most hazardous damage is likely DNA double-
strand breaks (DSB) that cleave the double helix 
backbone. DSBs occur naturally during T-cell 
receptor and immunoglobulin gene 
recombination in lymphocytes. DSBs can also 
arise as a consequence of exogenous stresses 
(e.g. ionizing irradiation, chemotherapeutic 
drugs, viruses) or oxidative processes. An 
increasing number of studies have reported that 
infection with pathogenic bacteria also alters the 
host genome, producing DSB and other 
modifications on DNA. This review focuses on 
recent data on bacteria-induced DNA damage 
and the known strategies used by these 
pathogens to maintain a physiological niche in 
the host. Even after DNA repair in infected cells, 
“scars” often remain on chromosomes and might 
generate genomic instability at the next cell 
division. Chronic inflammation in tissue, 
combined with infection and DNA damage, can 
give rise to genomic instability and eventually 
cancer. A functional link between the DNA 
damage response and the innate immune 
response has been recently established. 
Pathogenic bacteria also highjack the host cell 
cycle, often acting on the stability of the master 
regulator p53, or dampen the DNA damage 
response to support bacterial replication in an 
appropriate reservoir. Except in a few cases, the 
molecular mechanisms responsible for DNA 
lesions are poorly understood, although ROS 
release during infection is a serious candidate for 
generating DNA breaks. Thus, chronic or 
repetitive infections with genotoxic bacteria 
represent a common source of DNA lesions that 
compromise host genome integrity. 
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Thousands of lesions occur on eukaryotic cell 
DNA during each cell cycle, ranging from a 
“simple” chemical modification on a unique base 
to more dramatic breaks affecting either one or 
both strands of the DNA double helix [1]. The 
maintenance of genome integrity is a vital 
process to ensure cell viability and renewal. 
DNA breaks have multiple origins, for example 
the physiological and programmed 
recombination of immunoglobulin and T-cell 
receptor loci in lymphocytes. Lesions also arise 
when DNA replication forks collapse. In addition 
to these natural sources, DNA impairments also 
occur in the presence of external genotoxic 
agents, such as radiation (X-ray, gamma-
radiation, UV), chemotherapeutic drugs, viruses 
or extremely genotoxic reactive oxygen and 
nitrogen species (ROS) generated in response to 
stress. In recent years, it has become clear that 
some bacterial infections alter the DNA of 
infected cells. From a historical point of view, 
Helicobacter pylori has been tremendously 
useful to unravel the mysteries in this domain 
[2]. In 2006, the discovery of the Escherichia 
coli genotoxin colibactin, which induces DNA 
double-strand breaks (DSBs), led to a major 
breakthrough in the field [3]. Within a few years, 
the genotoxicity of many bacteria has been 
described. Recent studies on this topic have 
provided increasing evidence strongly supporting 
a link between bacterial infection and cancer.  
 
The signaling and repair of DNA double 
strand breaks 
DSBs only represent a minor percentage of the 
genome damage observed under basal 
endogenous conditions (10 to 50 DSBs versus 
more than 50,000 single strand breaks in each 
cell per day) or following a genotoxic stress [4, 
5]. However, DSBs are certainly the most life-
threatening lesions for the cells. A single 
unrepaired lesion can induce cell death, while an 
imperfect repair can trigger genomic instability 
and chromosomal rearrangement [4, 5]. The 
detection and signaling of DSB lesions occurs 
through a network of proteins involving a 
phosphorylation pathway, followed by an 
ubiquitination cascade (Fig. 1a-b). These events 
take place in nuclear foci ranging from 300 to 
600 nm in size [6, 7], called Ionizing Radiation 
Induced Foci (IRIF). Histone H2AX 
phosphorylation on serine 139 (γH2AX) though 
Ataxia Telangiectasia Mutated kinase (ATM) or 
related phosphatidylinositol 3-kinase-like kinase 
(PI3KK) family members, Ataxia telangiectasia 
and Rad3-related (ATR) and DNA protein kinase 
(DNA-PK), represents a key step in DSB 
signaling. γH2AX deposit spreads over several 
megabases around the break site, facilitating 
signal amplification [8, 9]. ATM activity leads to 
p53 stabilization and subsequent cell cycle arrest 
to prevent the replication of damaged DNA [1, 
4]. Depending on the extent of the DNA lesions, 
cells can enter apoptosis, repair DNA or become 
senescent (Fig. 1a). DSBs are repaired through 
two primary mechanisms, homologous 
recombination (HR) and non-homologous end 
joining (NHEJ) [1, 4]. At the S/G2 transition of 
the cell cycle, once DNA has been newly 
replicated, the HR pathway is preferentially 
activated. This repair is accurate, without 
information loss, due to the presence of a DNA 
matrix strand as a template. NHEJ operates in 
other cell cycle configurations. As no original 
matrix is present, NHEJ repair is often associated 
with a loss of information, and thus, this repair 
process is potentially mutagenic.   
 
Helicobacter pylori alters content and 
maintenance of the host genome 
Helicobacter pylori is a Gram-negative 
bacterium that colonizes the stomach in half of 
the population worldwide. Approximately 80% 
of the infected individuals remain asymptomatic; 
however, the remaining 20% of infected 
individuals develop chronic gastritis when left 
untreated [10]. H. pylori has been associated 
with gastric cancer, in the context of chronic 
infection and gastric mucosa inflammation. 
Previous studies have shown that H. pylori 
infection alters the content and maintenance of 
the eukaryotic genome [2]. Cells infected with 
this bacterium show a reduction in the synthesis 
of DNA mismatch repair proteins [11] and base 
excision repair proteins [12, 13], thereby 
increasing the risk of mutation frequency in 
gastric cells. Indeed, mutation frequencies are 
more elevated in mice infected with H. pylori, 
with a prevalence of transversion mutations (AT 
to GC and GC to AT), resulting from oxidative 
DNA damage [14]. Umeda and co-workers 
showed that CagA, a virulence factor delivered 
into H. pylori- infected cells delays prophase and 
metaphase, resulting in the incorrect orientation 




of the mitotic spindle and an abnormal division 
axis, generating anomalies in chromosome 
segregation and genomic instability [15]. H. 
pylori also alters the level of the pro-apoptotic 
regulator p53 through the promotion of 
ubiquitin-dependent proteasome degradation in a 
CagA-dependent manner [16, 17]. H. pylori is 
considered an extracellular pathogen, although 
these bacteria are occasionally internalized by 
gastric cells; however, interactions with the host 
provide a benefit for the bacterium (nutrients, 
limited competition at low pH, etc…) that 
establishes and maintains a chronic stomach 
infection in host and delays the death of infected 
cells [17]. 
In 2011, studies showed that H. pylori 
infections induce DSBs in gastric epithelial cells. 
Nuclear IRIF-like foci (induced by bacteria) 
containing γH2AX, 53BP1 and MDC1 have been 
observed in ATM kinase-dependent processes 
[18]. Large breaks on chromatids are detected at 
metaphases in infected cells, and these defects 
are independent of the bacterial virulence factors 
tested [18]. H. pylori infection generates ROS, 
but, despite a temporal correlation, ROS 
production is not required for the generation of 
DSBs. The eradication of H. pylori using 
antibiotics leads to efficient DSB repair and cell 
survival [18]. Nevertheless, when the infection 
persists over an extended period of time, residual 
unrepaired breaks remain, reflecting the 
saturation of the repair machinery, resulting in a 
loss of cell viability. The occurrence of DSBs, 
followed by imprecise repair, might explain the 
carcinogenic properties of H. pylori and 
contribute to the frequent chromosomal 
abnormalities observed in gastric cancers. 
 
Escherichia coli genotoxin colibactin  
Escherichia coli is an abundant bacterium 
present in the gut microbiota where it contributes 
to different functions such as food processing, 
immune system tuning, vitamin K2 production or 
protection against pathogenic microorganisms 
[19]. In vivo, gut colonization begins a few days 
after birth and persists for an entire lifetime. The 
bacteria-host association typically provides 
reciprocal benefits; nonetheless, some 
pathogenic strains of E. coli have deleterious 
effects in the intestine. The pathogenicity of E. 
coli belonging to B2 phylogenic group is 
associated with the presence of a genomic island 
called pks, which harbors approximately 20 open 
reading frames involved in the biosynthesis of 
the genotoxin colibactin [3]. This molecule is a 
hybrid nonribosomal polypeptide-polyketide 
compound resulting from the enzymatic 
activities encoded by the pks gene cluster. 
However, the precise structure of colibactin has 
not been solved so far. 
The in vitro infection of eukaryotic cells with 
E. coli carrying a pks island results in DSBs 
which trigger the activation of ATM kinase and 
downstream signaling pathways and effectors, 
such as Chk2 and Chk1 [3] (Fig. 1a). Chk1 and 
Chk2 subsequently phosphorylate Cdc25 
phosphatase, thereby inactivating this enzyme 
and inducing cell cycle arrest at the G2/M or 
G1/S transition. DSBs are observed in 
enterocytes of the colon mucosa of mice infected 
with E. coli pks+ [20]. At low multiplicity of 
infection (MOI), cells repair DNA and resume 
cell division, but massive cell death is observed 
in cells deficient in the NHEJ repair pathway 
[20]. In addition, some cells maintain γH2AX 
foci, like scars of infection, and chromosomal 
aberrations. Infection can also promote 
aneuploidy (gain or loss of chromosomes) or 
tetraploidy (8n cells) as a consequence of 
division anomalies. Moreover, an increase in 
mutation frequency is observed and cells acquire 
an enhanced capacity to grow in semi-liquid 
medium, as an early sign of cell transformation 
[20]. Under these conditions, it is likely that the 
multiple lesions induced by colibactin 
accumulate with time, perhaps contributing to 
the cell transformation process, a critical step 
before cancer onset. 
During massive infection, with a high MOI, 
cell cycle arrest occurs after DNA breaks, and 
the cells enter into a senescence phase, during 
which division is no longer observed [21, 22]. 
Large γH2AX foci might subsist in these 
senescent cells. After a few days, intracellular 
and mitochondrial ROS are produced and, 
interestingly, senescence propagates in vitro to 
neighboring non-infected cells through a 
bystander effect [21]. ROS and secreted factors 
might be implicated in the transmission of the 
information to adjacent cells. Senescence is a 
functional alternative to apoptosis, as a last resort 
to prevent cells carrying DNA lesions from 
undergoing transformation and becoming 
cancerous. However, another role for senescence 




has been proposed by Cougnoux and co-workers 
who observed that metabolically active senescent 
cells, generated after a high MOI-infection with 
E. coli pks+ strains, secreted growth factors, in 
particular the hepatocyte growth factor (HGF) 
[23]. Infection with E. coli pks+ also induced a 
downregulation of SENP1, a negative regulator 
of p53 SUMOylation. Indeed an increase in p53 
SUMOylation, a modification known to be 
associated with cellular senescence, was detected 
after infection. These events are dependent on a 
microRNA repressing SENP1 expression, MiR-
20a-5p, which synthesis is increased following 
infection with E. coli pks+ [23]. These data were 
obtained in vivo on mouse models and human 
colon adenocarcinoma biopsy specimens. So 
tumor growth observed in E. coli pks+ infected 
mice or human colon might be supported by 
growth factor production secreted by senescent 
cells [23]. 
A functional pks island generating DSBS has 
been identified in the genomes of enterobacteria 
other than E. coli, such as Citrobacter koseri, 
Enterobacter aerogenes and Klebsiella 
pneumoniae [24, 25]. Mice infected with K. 
pneumonia pks+ shows DSBs within 1 to 2 days 
in liver parenchymal cells only in the presence of 
colibactin [24]. In Taiwanese populations, K. 
pneumoniae is the most predominant pathogen 
associated with pyogenic liver abscess, an 
infection suspected to increase the risk of 
colorectal cancer development [25]. Additional 
studies are required to examine this hypothesis.  
 
E. coli at the gut microbiota scale 
In the last ten years, it has become 
increasingly clear that the microbiome, the pool 
of bacteria present in a specific organism, plays a 
role in promoting tumor formation in various 
organs [26 and references therein]. The 
microbiome, often called the “forgotten organ”, 
contains a metagenome one hundred-fold larger 
than the human genome [26]. Recent studies of 
the commensal bacteria present in the colon of 
wild type and deficient mice have provided new 
information concerning infections caused by 
pathogenic E. coli strains. Arthur et al. used a 
model of inflammatory interleukine-10 KO mice 
(IL10 -/-), which developed intolerance to self-
intestinal microbiota, chronic inflammation and 
colitis [27]. A comparison between wild type and 
IL10 -/- mice revealed that mice with 
inflammation harbor a microbiota enriched with 
several bacterial groups while maintaining a 
constant total bacteria number [27]. Surprisingly, 
the quantity of E. coli enterobacteria is increased 
100-fold in mice with inflammation. Moreover, a 
positive correlation was observed between 
cancer induced through the carcinogenic 
compound azoxymethane, which causes colon 
carcinomas, and the inflammatory state of mice 
[27]. Although the overall inflammation in the 
intestine remains unchanged upon colibactin 
expression, E. coli pks+ strains promote more 
colon tumors in mice compared with isogenic 
strains devoid of pks island and a deeper invasion 
of tissues. Human biopsies showed the 
overexpression of E. coli pks+ in colon 
carcinoma (66.7%) and intestinal inflammatory 
diseases (40%) compared with control patients 
without clinical manifestations (20.8%) [27]. 
Another study confirmed the high prevalence of 
pks-positive E. coli in patients with colon cancer 
[28]. 
Together, these data suggest that the chronic 
inflammation of the bowel in mice and human 
patients supports the expansion of 
microorganisms with genotoxic capabilities, 
which in turn promotes carcinogenesis. Thus, the 
inflammatory state creates an appropriate 
environment that facilitates bacteria-induced 
tumorigenesis [27]. 
These data were extended through a 
longitudinal analysis in mice (germ-free mice 
transferred to a conventional facility or infected 
with a single E. coli pks+ strain) to further 
explore the interplay between an endogenous 
microbial community, inflammation and host 
carcinogenesis [29]. E.coli adaptation to the 
mammalian intestine induces significant changes 
to the microbial transcriptome [29]. Surprisingly, 
inflammation only alters a small number of 
microbial genes (< 0.5% of E. coli genes), and 
even less microbial genes are affected at later 
stages after colonization. Sixty six genes are 
influenced by the cancer status (colorectal cancer 
induced by azoxymethane) and the pks island 
was among the top five operons (out of 448) 
upregulated at the dysplasia/pre-cancer stage 
[29]. Thus, the cancer microenvironment might 
impact the functional potential of E. coli to 
promote cancer progression through the 
modulation of the expression of specific bacterial 
genes. These data might constitute a first step in 




understanding how alterations in microbial 
richness and transcription occur in the host 
during inflammation. 
As a consequence of the genotoxic activity 
observed in pathogenic bacteria, some 
therapeutic strategies using E. coli Nissle 1917 as 
a probiotic treatment in intestine disorders, such 
as Crohn’s disease or ulcerative colitis, has been 
called into question. Indeed, E. coli Nissle 1917 
harbors a functional pks island that induces 
DSBs in the host cell genome [30]. The deletion 
of colibactin genes to improve the biosafety of 
this strain resulted in the loss of anti-
inflammatory activities [30]. Therefore, the 
health benefit versus the risk factor should be 
evaluated when long-term uses are expected.  
 
It has been well established that colibactin 
induces DNA damage, but the mechanisms and 
complete structure of this polyketide-polypeptide 
compound have not been elucidated. Recent 
studies have shown that the prodrug scaffold is 
cleaved off during the conversion of 
precolibactin to colibactin [31, 32]. Colibactin 
could act indirectly, for example, by inducing 
oxidative stress that triggers the release of free 
radicals reacting with DNA strands [33]. 
However, ROS are not immediately detected 
after infection, but rather a couple of days later 
[21], suggesting the early action of other factors, 
possibly nuclease(s).  
 
CDT bacterial DNase targets the eukaryotic 
genome.  
Cytolethal Distending Toxin (CDT) is the first 
toxin identified for blocking the G2/M transition 
of the cell cycle [34, 35]. Many gram-negative 
pathogenic bacteria such as Haemophilus 
ducreyi, Campylobacter jejuni, E. coli, Shigella 
dysenteriae, Salmonella typhi, and Helicobacter 
hepaticus, produce this toxin comprising 3 
subunits, CdtA, CdtB and CdtC. While CdtA and 
CdtC are crucial for holotoxin internalization, 
CdtB harbors structural and functional 
similarities to mammalian DNase I [34, 36]. 
CDT is secreted from bacteria prior to binding to 
the cell surface where this enzyme is internalized 
through endocytosis via several trafficking 
pathways and subsequently relocalized to the 
eukaryotic nucleus [36]. The microinjection of 
purified CDT in the cell nucleus triggers 
chromatin fragmentation [37]. In the presence of 
high doses of CDT, cells rapidly accumulate 
DSBs [36-38] with the concomitant formation of 
nuclear IRIF-like foci containing γH2AX and 
53BP1 [37, 39, 40] and the strong activation of 
ATM-Chk2 and ATR-Chk1 signaling axes [40]. 
Depending on the type of cells challenged with 
CDT, the activation of the ATM-Chk2-p53 
pathway results in G1 and /or G2 arrest, followed 
by cell death [41]. Epithelial or mesenchymal 
cells intoxicated with CDT die after several days, 
whereas more fragile lymphocytes die more 
rapidly through apoptosis [36]. In yeast, 
homologous recombination is the predominant 
DNA repair mechanism for protection against 
CDT-induced lesions [42], whereas in human 
cells, both HR and NHEJ repair pathways protect 
against CDT-induced DSBs [40]. At low doses, 
CDT primarily generates SSBs which are 
converted into DSBs during the S-phase [43, 44]. 
It was recently shown that chronic exposure to 
CDT could induce genomic instability in rat 
fibroblasts andcolorectal carcinoma cell lines 
[44]. Moreover, CDT promotes anchorage-
independent growth and enhances mutation 
frequency, with a majority of point mutations 
leading to amino acid substitutions [45]. CDT 
activity has also been associated with the 
activation of small RhoA GTPases and actin 
stress fiber formation in an ATM kinase-
dependent manner [38]. Normal or cancerous 
cells that survive the acute intoxication phase 
induced through CDT exhibit characteristics of 
senescence, with the sustained activation of 
DNA repair pathways and β−galactosidase 
activity typical of senescent cells [39]. 
CDT is the first bacterial toxin for which 
information on the mechanisms leading to DNA 
damage is available. Up to now, no direct 
relation between CDT and cancer has been 
established. However, this toxin functions as a 
radiomimetic agent [40], triggering genomic 
instability and increasing mutation frequency, 
thereby supporting this possibility. 
 
Pseudomonas and DNA damage  
Pseudomonas aeruginosa, an opportunist 
pathogen responsible for nosocomial infections, 
is a multi-resistant bacterium that primarily 
infects immunocompromised individuals (i.e., 
those with AIDS or who have undergone 
chemotherapy), cystic fibrosis patients, and those 
undergoing invasive surgery or suffering from 




severe skin damage [46, 47]. The pathogenicity 
associated with chronic or acute infection is 
multifactorial. Upon chronic infection, bacteria 
frequently form biofilms, a community of 
bacteria embedded in a self-produced polymer 
matrix that confers protection and increases 
resistance. Bacteria grow more slowly in 
biofilms and often exhibit lower virulence [48]. 
However, acute and severe infections are 
associated with the presence of the type three 
secretion system (TTSS), a major bacterial 
virulence system [48-50]. The TTSS system 
comprised an inducible needle-like structure at 
the surface of the bacterium, through which 
bacterial toxins are directly injected into the host 
cytoplasm [51]. In cell culture, P. aeruginosa 
with a functional TTSS induces DSBs and IRIF-
like foci formation, that, in addition to γH2AX, 
contains 53BP1, a late effector in signaling and 
DNA repair cascades [52] (Figure 1a). At low 
MOI (10 bacteria/cell), H2AX is phosphorylated 
within one hour of contact with bacteria, without 
any signs of cell death or apoptosis at this time. 
Among the four potential toxins injected into 
host cells, ExoS and to a much lesser extent its 
related exoenzyme ExoT contribute to H2AX 
phosphorylation. The inactivation of ATM 
kinase with chemical inhibitors, deletion of ExoS 
or mutation of the ExoS ADP-ribosyl transferase 
domain severely impairs pathogen-induced 
H2AX phosphorylation [52]. Unlike CDT, ExoS 
does not possess any known nuclease activity, 
thus the direct mechanisms leading to DSBs 
remain elusive in P. aeruginosa. DSBs could 
result from the ROS-related oxidation of DNA, 
or similar to H. pylori, these lesions could be 
associated to ROS release, without dependence 
on these molecules [18]. 
Another study on P. aeruginosa genotoxicity 
showed that the synthesis of OGG1 (8-
oxoguanine DNA glycosylase), an enzyme 
involved in the base excision repair pathway, 
increased during infection [53]. OGG1 
participates in the recognition and elimination of 
the genome of 8-oxoguanine, a potentially 
mutagenic product resulting from oxidative 
damage [53, 54]. The deletion of OGG1 in mice 
exacerbates lung injury following P. aeruginosa 
infection compared with control mice, 
highlighting the important role of OGG1 in 
protection and DNA repair [53]. Furthermore, 
the accumulation of 8-oxoguanine in OGG1-
deficient mice has been associated with a strong 
inflammation in the lungs [53].  
Other Pseudomonas species, such as 
Pseudomonas syringae, can generate DSBs and 
induce γH2AX production in Arabidopsis 
thaliana [55]. Surprisingly, neither ATM nor 
ATR are involved in this process, and no DNA-
PK kinase gene is present in the Arabidopsis 
genome [55]. Similar to P. aeruginosa, TTSS-
defective mutants of P. syringae show a reduced 
capacity to induce DSBs, suggesting the 
contribution of at least one type three effector 
[55]. P. syringae harbors a TTSS ADP-ribosyl 
transferase, involved in plant innate immunity 
suppression [56], but no association with DSBS 
formation has been reported for this enzyme. 
Plants harboring a mutated NADPH oxidase or 
treated with paraquat, an herbicide inducing a 
strong ROS production, do not display changes 
in γH2AX production upon infection, suggesting 
that ROS are not the primary cause of DSBs 
induced by P. syringae [55]. Additional studies 
should help clarify the complete mechanisms of 
P. syringae-induced DSBs in plants. 
 
In summary, P. aeruginosa induces several 
types of DNA alterations, such as SSBs, DSBs or 
oxidative DNA damage, subsequently activating 
several pathways to repair these lesions. An 
alternative to cell death is conceivable if the cells 
repair DNA, maybe during a limited infection or 
after efficient antibiotherapy. A single surviving 
cell, with inaccurate DNA repair, could undergo 
cell transformation and initiate tumorigenesis in 
a permissive environment. Although this 
possibility remains a working hypothesis, this 
question has been recently raised, particularly in 
patients with high intestinal P. aeruginosa 
carriage [52, 57]. Indeed, opportunistic 
pathogens, such as P. aeruginosa, are present in 
human healthy intestines and, in intensive care 
units, the intestinal tract is considered as the 
most important reservoir for P. aeruginosa [58, 
59]. Furthermore patients staying at the hospital 
and patients undergoing chemotherapy or 
systemic exposure to antibiotics exhibit higher P. 
aeruginosa intestinal carriage than the control 
populations (57 and references therein). 
Undoubtedly, future studies will explore these 
new potential routes. 
 




Strains of Shigella, Neisseria, Listeria and 
Chlamydia are also genotoxic 
The bacterium Shigella flexneri infects the 
colonic and rectal epithelium in humans, causing 
destructive rectocolitis, acute gastroenteritis, also 
called shigellosis or bacillary dysentery. Bacteria 
replicate in infected cells, triggering 
inflammation and tissue destruction. This 
pathogen utilizes mechanisms different from 
those used by E. coli and H. pylori, and 
maintains a live epithelial cellular reservoir, 
despite DNA break production [60]. S. flexneri 
induces ATM activation and H2AX 
phosphorylation, but these signals do not result 
in p53 stabilization, followed by rapid cell death 
(Fig. 2a). In contrast, this bacterium activates 
cellular proteases of the calpain family, in a VirA 
virulence factor-dependent manner. Calpains 
then promote p53 degradation, leading to the 
inhibition of the p53-dependent pro-apoptotic 
pathway [60, 61]. Bacteria highly proliferate in 
infected cells before cell death through necrosis 
[61]. How does S. flexneri damage DNA and 
why does it first induce genotoxicity? The 
answer remains unknown, but by interfering with 
the signaling pathway for DNA damage, bacteria 
increase survival and replication by avoiding 
premature death of host cells. 
 
Similar to S. flexneri, Neisseria gonorrhoeae 
alters the p53 signaling pathway upon eukaryotic 
cell infection. This bacterium infects more than 
one hundred million individuals each year 
worldwide and causes gonorrhea, a common and 
curable sexually transmitted infection [62]. Upon 
infection, Vielfort and colleagues have shown 
that tumor and non-tumor epithelial cells derived 
from human vaginal or cervical mucosa exhibit 
SSBs and DSBs, with the formation of IRIF-like 
foci containing γH2AX and 53BP1 [63]. One day 
after infection, the levels of p21 and p27 cyclin-
dependent kinase inhibitors increase, while p53 
level decreases in non-tumor epithelial cells. Cell 
cycle analysis indicated that gonococcal 
infection delays the progression through the G2, 
resulting in the accumulation of infected cells in 
G1 [63]. The down regulation of p53 could 
potentially be a mechanism developed in N. 
gonorrhoeae to maintain host cell survival 
despite DNA damage. Thus, the epithelial cell 
lining of the urogenital tract is a protected niche, 
where gonococci survive and multiply in the host 
cytoplasm, evading extracellular immune 
responses. Although the cells efficiently repair 
strand breaks during persistent gonococcal 
infection, increased DNA damage intensifies the 
pressure on DNA repair machinery, which can 
eventually become overwhelmed with time, an 
important factor predisposing to malignancies. 
 
Listeria monocytogenes, another player 
responsible for listeriosis, causes severe intra-
uterine infections, bacteremia or central nervous 
system infections, primarily in 
immunocompromised or fragile patients. This 
bacterium, an intracellular facultative pathogen 
present in contaminated food, is able to cross 
both the intestine and placenta barriers and 
spread from cell to cell. It has been shown that L. 
monocytogenes induces DSBs and γ H2AX at 
very low MOI (less than 1 bacterium per cell) 
[64]. This process is independent on the toxin 
lysteriolysin O (LLO), a pore-forming toxin with 
cytolytic activity localized at the plasma 
membrane [64], and bacterial internalization is 
not necessary for inducing host cell DNA 
damage [65]. Infection with L. monocytogenes 
increases host cell cycle duration without 
compromising cell viability and infected cells 
continue division to generate two infected cells 
[64]. In contrast to other bacteria that halt the cell 
cycle, L. monocytogenes only induces a delay in 
the DNA synthesis phase, facilitating DNA 
repair. This time frame has also been suggested 
as an auspicious opportunity for the duplication 
of L. monocytogenes, taking advantage of the 
host resources for bacterial division. The host 
DNA damage response (DDR) induced by L. 
monocytogenes is atypical, as DNA-PK kinase is 
activated rather than the related kinases ATM or 
ATR [64]. L. monocytogenes does not possess 
any known toxin for damaging DNA. In addition 
this microorganism inhibits ROS production 
through the activity of LLO toxin [66]. Thus, it 
has been suggested that L. monocytogenes likely 
utilizes strategies other than oxidative damage to 
alter the host genome. 
A recent study conducted at the Pasteur 
Institute provided an additional piece of 
information on the complex mechanism used by 
L. monocytogenes to control the host DDR [65]. 
Although this bacterium induces DNA breaks in 
vitro and in vivo, researchers have shown that 
this invasive bacterium elicits unexpectedly low 




DDR via the activity of the LLO toxin. L. 
monocytogenes mutants lacking LLO induce a 
much higher DDR, whereas bacteria 
overexpressing the LLO toxin trigger lower DDR 
than wild-type bacteria [65]. Surprisingly, the 
pretreatment of cells with purified LLO inhibits 
DDR induced with extremely powerful 
genotoxic agents, such as gamma-irradiation and 
etoposide. The remarkable effects of LLO are 
mediated through the proteasome-independent 
degradation of Mre11, a key sensor of the MNR 
complex acting at the earliest steps of DSB 
signaling (Fig. 2a). Without the Mre11 sensor, 
DDR is impaired. The targeted reduction of 
several components of the DDR (including 
ATM, 53BP1 and H2AX, along with Mre11) 
substantially promotes L. monocytogenes 
replication, indicating that the host DDR acts as 
a negative regulator of infection [65]. The events 
downstream LLO leading to Mre11 degradation 
and DDR dampening are only beginning to 
emerge. Other genome alterations have been 
reported following L. monocytogenes infection. 
Indeed, this bacterium acts on host chromatin 
through histone deacetylation by Sirtuin 2 
deacetylase, resulting in the repression of a set of 
genes [67]. Thus L. monocytogenes manipulates 
the eukaryotic genome through multiple 
mechanisms to promote the survival and 
replication of this bacterium. 
 
A similar strategy has been described for the 
obligate intracellular pathogen Chlamydia 
trachomatis, a bacterium associated with cervical 
and ovarian cancers. Due to its small genome, 
this bacterium depends on the uptake of amino 
acids and nucleotides from the host for survival 
and replication [68]. Thus, similar to most 
obligate intracellular bacteria, Chlamydia exists 
in a conflictual situation, as metabolites from a 
living host are needed, although Chlamydia 
harms the host cells. Indeed, acute and persistent 
infections with C. trachomatis alters histone 
epigenetic marks, including the sustained 
upregulation of γH2AX and the formation of 
senescence-associated heterochromatin foci [69]. 
C. trachomatis-induced ROS contribute to DSB 
formation; remarkably, Mre11, ATM and 53BP1 
are inhibited from binding to damaged DNA, 
impeding the repair of DNA, activation of the 
downstream cell cycle checkpoint regulators 
Chk1 and Chk2 and the death of the cells [69]. 
Instead, infection promotes cell survival by 
limiting the extent of DNA damage signaling, 
similar to the effects of L. monocytogenes 
infection. C. trachomatis infection also activates 
the MDM2 ubiquitin ligase, or the human 
homolog HDM2, which causes ubiquitinated-p53 
proteasomal degradation (Fig. 2a) [70, 71]. An 
important role for stabilized p53 implies the 
downregulation of several metabolic pathways, 
including the pentose phosphate pathway which 
promotes DNA repair and provides essential 
metabolites for Chlamydia growth. As a 
consequence of p53 degradation, the repression 
of the pentose phosphate pathway is prevented 
upon infection, thereby facilitating Chlamydia 
proliferation [70] The inhibition of p53-MDM2 
axis is sufficient to disrupt the intracellular 
proliferation of Chlamydia and to overcome the 
anti-apoptotic effects of this bacterium on host 
cells [70, 71]. Thus, these authors have 
demonstrated a novel antibacterial role for p53. 
After Chlamydia clearance through 
doxycyclin treatment, reduced p53 binding 
activity associated with a concomitant 
downregulation of the target gene p21 and a 
sustained resistance to etoposide-induced 
apoptosis is still detected in host cells [72]. 
Therefore, even when Chlamydia has been 
eradicated, surviving host cells exhibit an altered 
physiology, which might increase the risk of 
further transformation in previously infected 
cells. 
Hence, host cells with damaged DNA and 
modified chromatin are compelled to survive, 
which likely predispose these cells to malignant 
transformation [69, 71, 72]. 
 
A functional connection between DNA 
damage and the immune response 
Recent studies have shown a functional 
connection between the innate immune response 
and DNA damage [73-76 for review]. Briefly, 
Mre11 and Rad50 are involved in the recognition 
of cytoplasmic double-stranded DNA (dsDNA), 
a potent immunostimulatory form of DNA 
resulting from bacterial or virus infection, 
cellular debris or replication damage. After 
binding to cytoplasmic dsDNA, Mre11 activates 
type 1 interferon (IFN) production through the 
stimulator of interferon genes (STING) pathway 
[77]. IFN primes the pattern recognition receptor 
system (PRR) [73] for amplified antimicrobial 




response through the production of cytokines and 
chemokines, and the recruitment of phagocytic 
cells [77]. Similarly, Rad50 forms a complex 
with cytosolic dsDNA and the innate immune 
system adaptor CARD9 (caspase recruitment 
domain family 9), resulting in the production of 
the highly proinflammatory Interleukin lβ after 
NF-κB pathway activation [78]. Moreover, ATM 
and DNA-PK have also been shown to be 
associated with cytoplasmic PRR. DNA-PK 
binds cytoplasmic DNA, triggering the 
transcription of IFN, cytokine and chemokine 
genes through the STING pathway [79]. 
Concerning ATM, Härtlova and co-workers have 
established that ATM-/- mice or AT patients 
(patients owing a deficient ATM protein) show 
the spontaneous elevation of IFN levels, which 
primes cells for amplified antiviral and 
antibacterial responses [80]. Moreover, IL1β 
production is also evidenced upon L. 
monocytogenes infection in this ATM-deficient 
environment. Unrepaired DNA damage 
constitutively present in ATM-/- mice or induced 
DNA damage in ATM +/+ mice primes type 1 IFN 
responses, which, similar to Mre11 and DNA-
PK, are mediated through the cytoplasmic DNA 
receptor STING [80]. In addition, cytoplasmic 
self-DNA release is detected in AT patients and 
ATM-/- mice, likely reflecting, at least in part, the 
spontaneous systemic inflammation present in 
AT patients [80]. 
Together, these studies demonstrate that 
essential factors of the DNA repair and signaling 
pathways also act as PRRs in the cytoplasm, 
connecting the genome defense pathway to the 
immune system (Fig. 3). 
 
Conclusion 
Quantitative estimations have revealed that the 
human body contains at least ten times more 
microorganisms than human cells [58]. Bacteria 
are essential in many aspects of human 
physiology, but the fine equilibrium between the 
host and microbial “residents” can be easily 
altered upon pathogenic infection or through 
subtle changes in the microbiome composition 
and/or expression. In the case of genotoxic 
bacterial infection, detrimental consequences 
arise not only at the cellular level, but also at the 
organ or whole body scale. 
Infection with genotoxic bacteria produces 
DSBs in the eukaryotic genome, a category of 
lesions that are highly dangerous for the cells. 
Many genotoxic strains have developed 
strategies to limit host DDR and avoid premature 
cell death. The development of these 
mechanisms could perhaps be interpreted as an 
evolutionary process that confers a selective 
advantage to genotoxic bacteria (Fig. 3). 
Genotoxic bacteria halt or delay the cell cycle 
through p53-induced-degradation, a highly 
abnormal behavior for compromised cells. 
Indeed, cells are forced to survive, despite the 
genome damage, while the intracellular 
pathogens replicate in the cytoplasm. Other 
intracellular pathogens such as L. monocytogenes 
or C. trachomatis impede the host DDR through 
the inhibition of upstream DSB sensors such as 
Mre11 and create appropriate conditions for their 
proliferation.  
The precise molecular mechanisms leading to 
bacteria-induced DNA damage remain largely 
unknown, except for bacteria possessing toxins 
with DNase activity, such as CDT. Infection 
causes an inflammatory immune response 
associated with ROS release, supporting the idea 
that reactive oxidative species are responsible for 
the DNA damage. This reality might not be quite 
as simple, as quenching ROS activity did not 
prevent the occurrence of DSBs. Thus, in many 
cases, additional studies are required to identify 
the molecules directly responsible for the DNA 
damage. 
At the organ level, studies on the gut 
microbiome and transcriptome have shown a 
tight association between the immune response, 
microbiome composition and tumor formation 
(Fig. 3). For E. coli, chronic inflammation in the 
gut triggers the expansion of more genotoxic 
strains expressing colibactin compared with 
those present in the microbiome of a healthy 
organism. Moreover, strain genotoxicity 
correlates with tumor formation in mice and 
humans in an inflammatory context. In addition, 
DDR itself elicits an immune response that 
contributes to inflammation, establishing a direct 
association between genome defense and the 
innate immune system (Fig. 3). 
 
Infected eukaryotic cells might survive 
infection. However, DNA from these cells often 
retains traces of infection, which can have 
deleterious consequences on genome integrity 
and stability. These alterations could represent a 




step toward cell transformation and 
tumorigenesis. Within the last 10 years, the 
number of bacteria identified as genotoxic has 
increased. This number should continue to 
expand in the future after a meticulous 
evaluation of the DNA-damaging capacities of 
all known pathogens. As the eradication of 
bacteria becomes more and more difficult due to 
increasing antibiotic resistance, this bacteria-
induced damage could evolve toward an 
important public health concern. Similar to UV 
in solar rays, chronic or repetitive infections with 
genotoxic bacteria represent a constant source of 
DNA lesions, which could definitely become 
dangerous if the effects accumulate over time.  
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Fig. 1 DNA signaling and repair pathways activated by genotoxic bacteria. a Detection and  signaling of DNA breaks. The sensor formed by the tripartite MNR complex (Mre11, Nbs1 and Rad50) has the intrinsic 
capacity to bind DNA. Upon DSBs, ATM is activated through auto-phosphorylation and phosphorylates MNR, H2AX, MDC1 and p53. γH2AX forms a high-affinity binding site for MDC1, which orchestrates the 
recruitment of later effectors to damaged chromatin. RNF8 and RNF168 ubiquitin-ligases ubiquitinate chromatin and stimulate the local binding of DNA repair proteins 53BP1 and BRCA1. Following p53 
phosphorylation through ATM or the activation of Chk1, Chk2 and Cdc25 through ATM/ATR pathways, the cell cycle is arrested at the G1/S or G2/M transition. This block facilitates DNA repair, preventing genome 
duplication and  cell division. The two major DSB repair pathways are  homologous recombination (HR) and the non-homologous end joining (NHEJ). HR requires a DNA template, and thus,  this pathway is primarily
active in the S or G2 phase. HR repair is accurate, without error or genetic loss. The NHEJ pathway functions  throughout the cell cycle and could lead to genetic information loss or mutation, as no original DNA 
matrix is used for repair. The cells resume the cell cycle once the repair has been completed. Defective repair could induce  genomic instability and eventually tumorigenesis or p53-dependent apoptosis. SSB and 
the presence of 8-oxoguanine are detected through poly(ADP-ribose) polymerases (PARP) and 8-oxoguanine DNA glycosylase (OGG1), respectively. The different bacteria or genotoxins discussed in the text are 
indicated in green. * Refers to the modifications on p53 and Mre11 proteins described in Fig. 2. b Nuclei harboring ionizing radiation-induced foci (IRIF) after genotoxic stress. Upon DSBs, phosphorylated H2AX 
molecules (γH2AX) accumulate over hundreds of kilobases on both sides of the break, forming  nuclear foci containing proteins of the DNA signaling and repair cascades. γH2AX is in red, 53BP1 in  green and DNA 











































Fig.2 Genotoxic bacteria degrade key components of the DDR pathway. a Several genotoxic bacteria strains affect the stability
of p53. When DSBs occur, ATM phosphorylates p53 which becomes stable, induces the expression of apoptotic genes and arrests
the cell cycle. In the absence of DSBs, p53 is ubiquitinated by MDM2 ubiquitine ligase (or HDM2, the human homologue) and then
degraded through the proteasome. H. pylori, N. gonorrhoeae, S. flexneri and C. trachomatis interfere with the normal pathway by
promoting p53 degradation and by inhibiting p53-dependent apoptosis. Sustained depletion of p53 is a key event for
C. trachomatis growth. U: ubiquitin, P: phosphorylation. b L. monocytogenes, through the action of Listeriolysin O (LLO), induces
proteasome-independent degradation of the DNA damage sensor Mre11, a component of the MNR complex. As a consequence,
the DDR is blocked, the cell cycle is not arrested and cells do not die. Inhibition of DDR is a beneficial feature for successful






















(IFN, IL1β, ...) 
PATHOGEN
ERADICATION
Fig.3 Three tightly interconnected pathways: Infection, host innate immune response and 
host DDR. Cytosolic dsDNA produced after DNA damage is recognized by cytosolic PRRs 
which are linked to the innate immune system. When localized in the cytoplasm, Mre11, 
Rad50 and DNA-PK have been shown to bind dsDNA, which induces an innate immune 
response through several signaling pathways involving PRRs.
